These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
696 related items for PubMed ID: 20685823
1. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Lavi-Moshayoff V, Wasserman G, Meir T, Silver J, Naveh-Many T. Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823 [Abstract] [Full Text] [Related]
2. Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH. Saji F, Shigematsu T, Sakaguchi T, Ohya M, Orita H, Maeda Y, Ooura M, Mima T, Negi S. Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1212-7. PubMed ID: 20739393 [Abstract] [Full Text] [Related]
3. Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. Kondo H, Guo J, Bringhurst FR. J Bone Miner Res; 2002 Sep; 17(9):1667-79. PubMed ID: 12211438 [Abstract] [Full Text] [Related]
4. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease]. Nagano N, Miyata S, Abe M, Wakita S, Kobayashi N, Wada M. Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627 [Abstract] [Full Text] [Related]
5. FGF23 and the parathyroid. Silver J, Naveh-Many T. Adv Exp Med Biol; 2012 Sep; 728():92-9. PubMed ID: 22396164 [Abstract] [Full Text] [Related]
6. 1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal-gastrointestinal-skeletal axis that controls phosphate transport. Kolek OI, Hines ER, Jones MD, LeSueur LK, Lipko MA, Kiela PR, Collins JF, Haussler MR, Ghishan FK. Am J Physiol Gastrointest Liver Physiol; 2005 Dec; 289(6):G1036-42. PubMed ID: 16020653 [Abstract] [Full Text] [Related]
7. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats. Román-García P, Carrillo-López N, Naves-Díaz M, Rodríguez I, Ortiz A, Cannata-Andía JB. Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717 [Abstract] [Full Text] [Related]
8. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis. Gutiérrez OM. Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957 [Abstract] [Full Text] [Related]
9. The fibroblast growth factor receptor mediates the increased FGF23 expression in acute and chronic uremia. Hassan A, Durlacher K, Silver J, Naveh-Many T, Levi R. Am J Physiol Renal Physiol; 2016 Feb 01; 310(3):F217-21. PubMed ID: 26311115 [Abstract] [Full Text] [Related]
10. Parathyroid hormone activates the orphan nuclear receptor Nurr1 to induce FGF23 transcription. Meir T, Durlacher K, Pan Z, Amir G, Richards WG, Silver J, Naveh-Many T. Kidney Int; 2014 Dec 01; 86(6):1106-15. PubMed ID: 24940803 [Abstract] [Full Text] [Related]
11. Effects of parathyroid hormone on Wnt signaling pathway in bone. Kulkarni NH, Halladay DL, Miles RR, Gilbert LM, Frolik CA, Galvin RJ, Martin TJ, Gillespie MT, Onyia JE. J Cell Biochem; 2005 Aug 15; 95(6):1178-90. PubMed ID: 15962290 [Abstract] [Full Text] [Related]
12. The bone histology spectrum in experimental renal failure: adverse effects of phosphate and parathyroid hormone disturbances. Batista DG, Neves KR, Graciolli FG, dos Reis LM, Graciolli RG, Dominguez WV, Neves CL, Magalhães AO, Custódio MR, Moysés RM, Jorgetti V. Calcif Tissue Int; 2010 Jul 15; 87(1):60-7. PubMed ID: 20428857 [Abstract] [Full Text] [Related]
13. Roles of PTH and FGF23 in kidney failure: a focus on nonclassical effects. Komaba H. Clin Exp Nephrol; 2023 May 15; 27(5):395-401. PubMed ID: 36977891 [Abstract] [Full Text] [Related]
14. Fgf23 and parathyroid hormone signaling interact in kidney and bone. Andrukhova O, Streicher C, Zeitz U, Erben RG. Mol Cell Endocrinol; 2016 Nov 15; 436():224-39. PubMed ID: 27498418 [Abstract] [Full Text] [Related]
15. Does the downregulation of the FGF23 signaling pathway in hyperplastic parathyroid glands contribute to refractory secondary hyperparathyroidism in CKD patients? Lafage-Proust MH. Kidney Int; 2010 Mar 15; 77(5):390-2. PubMed ID: 20150940 [Abstract] [Full Text] [Related]
16. SOST is a target gene for PTH in bone. Keller H, Kneissel M. Bone; 2005 Aug 15; 37(2):148-58. PubMed ID: 15946907 [Abstract] [Full Text] [Related]
17. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Stubbs J, Liu S, Quarles LD. Semin Dial; 2007 Aug 15; 20(4):302-8. PubMed ID: 17635819 [Abstract] [Full Text] [Related]
18. Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone. Iwasaki-Ishizuka Y, Yamato H, Nii-Kono T, Kurokawa K, Fukagawa M. Nephrol Dial Transplant; 2005 Sep 15; 20(9):1904-11. PubMed ID: 15985520 [Abstract] [Full Text] [Related]
19. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis. Koizumi M, Komaba H, Fukagawa M. Contrib Nephrol; 2013 Sep 15; 180():110-23. PubMed ID: 23652554 [Abstract] [Full Text] [Related]
20. The interaction of PTH and dietary phosphorus and calcium on serum calcitriol levels in the rat with experimental renal failure. Martin-Malo A, Rodriguez M, Martinez ME, Torres A, Felsenfeld AJ. Nephrol Dial Transplant; 1996 Aug 15; 11(8):1553-8. PubMed ID: 8856210 [Abstract] [Full Text] [Related] Page: [Next] [New Search]